Trials / Completed
CompletedNCT05164159
The Comparison of Hemodynamic Effects Between Remimazolam-remifentanil and Propofol-remifentanil in Patients Undergoing Laparoscopic Cholecystectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 274 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 19 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
This study is conducted to determine whether the occurrence of hypotension is reduced by the combined use of remimazolam and remifentanil compared to the conventional combination use of propofol and remifentanil. Patients enrolled in the study are infused continuously with either propofol or remimazolam from the start of anesthesia to the end of surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | propofol group | During induction, the propofol group starts the effect site concentration at 4.0 ng/ml with TCI and adjusts it to around 3.0 \~ 4.0 ng/ml after intubation to maintain an appropriate EEG-based depth of anesthesia. |
| DRUG | remimazolam group | In the remimazolam group, start remimazolam at 6 mg/kg/hr and adjust it to 1 mg/kg/hr after loss of consciousness to maintain an appropriate EEG-based depth of anesthesia. |
Timeline
- Start date
- 2022-02-20
- Primary completion
- 2022-08-22
- Completion
- 2022-08-22
- First posted
- 2021-12-20
- Last updated
- 2022-11-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05164159. Inclusion in this directory is not an endorsement.